surface engineering
Recently Published Documents


TOTAL DOCUMENTS

2215
(FIVE YEARS 748)

H-INDEX

90
(FIVE YEARS 19)

2022 ◽  
Vol 66 ◽  
pp. 295-305 ◽  
Author(s):  
Bo Zhao ◽  
Jin Li ◽  
Maxime Guillaume ◽  
Jolien Dendooven ◽  
Christophe Detavernier

2022 ◽  
Vol 46 ◽  
pp. 103786
Author(s):  
Chongjun Zhao ◽  
Jingjia Guo ◽  
Jingtao Fan ◽  
Xu Zhang ◽  
Chunhua Zhao ◽  
...  

2022 ◽  
Vol 7 ◽  
pp. 100188
Author(s):  
Ivan Guryanov ◽  
Ekaterina Naumenko ◽  
Rawil Fakhrullin

ACS Catalysis ◽  
2022 ◽  
pp. 1686-1696
Author(s):  
Shijie Ren ◽  
Mao Sun ◽  
Xiaotian Guo ◽  
Xianhu Liu ◽  
Xueyuan Zhang ◽  
...  

Membranes ◽  
2022 ◽  
Vol 12 (1) ◽  
pp. 85
Author(s):  
Hojun Choi ◽  
Hwayoung Yim ◽  
Cheolhyoung Park ◽  
So-Hee Ahn ◽  
Yura Ahn ◽  
...  

Among extracellular vesicles, exosomes have gained great attention for their role as therapeutic vehicles for delivering various active pharmaceutical ingredients (APIs). Exosomes “armed” with anti-cancer therapeutics possess great potential for an efficient intracellular delivery of anti-cancer APIs and enhanced targetability to tumor cells. Various technologies are being developed to efficiently incorporate anti-cancer APIs such as genetic materials (miRNA, siRNA, mRNA), chemotherapeutics, and proteins into exosomes and to induce targeted delivery to tumor burden by exosomal surface modification. Exosomes can incorporate the desired therapeutic molecules via direct exogenous methods (e.g., electroporation and sonication) or indirect methods by modifying cells to produce “armed” exosomes. The targeted delivery of “armed” exosomes to tumor burden could be accomplished either by “passive” targeting using the natural tropism of exosomes or by “active” targeting via the surface engineering of exosomal membranes. Although anti-cancer exosome therapeutics demonstrated promising results in preclinical studies, success in clinical trials requires thorough validation in terms of chemistry, manufacturing, and control techniques. While exosomes possess multiple advantages over synthetic nanoparticles, challenges remain in increasing the loading efficiency of anti-cancer agents into exosomes, as well as establishing quantitative and qualitative analytical methods for monitoring the delivery of in vivo administered exosomes and exosome-incorporated anti-cancer agents to the tumor parenchyma.


2022 ◽  
Author(s):  
Haoran Mu ◽  
Wenzhi Yu ◽  
Jian Yuan ◽  
Shenghuang Lin ◽  
Guangyu Zhang

Abstract Since being rediscovered as an emerging 2D material, BP with extraordinary energy structure and unusually strong interlayer interactions offer new opportunities for optoelectronics and photonics. However, due to the thin atomic body and the ease of degradation with water and oxides, BP is highly sensitive to the surrounding environment. Therefore, high-quality engineering of interfaces and surfaces plays an essential role in BP-based applications. In this review, begun with a review of properties of BP, different strategies of interface and surfaces engineering for high ON-OFF ratio, enhanced optical absorption, and fast optical response are reviewed and highlighted, and recent state-of-the-art advances on optoelectronic and photonic devices are demonstrated. Finally, the opportunities and challenges are outlooked for future BP-related research.


2022 ◽  
Vol 23 (2) ◽  
pp. 701
Author(s):  
Yuki Ito ◽  
Takuya Araki ◽  
Shota Shiga ◽  
Hiroyuki Konno ◽  
Koki Makabe

Top7 is a de novo designed protein whose amino acid sequence has no evolutional trace. Such a property makes Top7 a suitable scaffold for studying the pure nature of protein and protein engineering applications. To use Top7 as an engineering scaffold, we initially attempted structure determination and found that crystals of our construct, which lacked the terminal hexahistidine tag, showed weak diffraction in X-ray structure determination. Thus, we decided to introduce surface residue mutations to facilitate crystal structure determination. The resulting surface mutants, Top7sm1 and Top7sm2, crystallized easily and diffracted to the resolution around 1.7 Å. Despite the improved data, we could not finalize the structures due to high R values. Although we could not identify the origin of the high R values of the surface mutants, we found that all the structures shared common packing architecture with consecutive intermolecular β-sheet formation aligned in one direction. Thus, we mutated the intermolecular interface to disrupt the intermolecular β-sheet formation, expecting to form a new crystal packing. The resulting mutant, Top7sm2-I68R, formed new crystal packing interactions as intended and diffracted to the resolution of 1.4 Å. The surface mutations contributed to crystal packing and high resolution. We finalized the structure model with the R/Rfree values of 0.20/0.24. Top7sm2-I68R can be a useful model protein due to its convenient structure determination.


2022 ◽  
Vol 131 (1) ◽  
pp. 011102
Author(s):  
Anton Nikiforov ◽  
Chuanlong Ma ◽  
Andrei Choukourov ◽  
Fabio Palumbo

Sign in / Sign up

Export Citation Format

Share Document